GHG Emissions, Industrial, Sourcing Renewables - July 5, 2022
BD Posts Energy Decrease, Renewables Increase
BD (Becton, Dickinson and Company) made progress toward its goal of 25% energy reduction by 2030 (from a 2019 baseline, normalized to cost of products sold), achieving 14% energy reduction in FY 2021, in addition to increasing its investment in on-site renewable energy.
The global medical technology company announced its 13 locations obtain 100% of their electric power from renewable sources and also committed to Scope 1, 2 and 3 GHG reduction targets in line with 1.5⁰C emissions scenarios to reach science-based net zero emissions by 2050.
Details were provided in its fiscal year 2021 Environmental, Social and Governance (ESG) Report.
"We are taking action to address the most relevant ESG issues for our business and stakeholders, including climate change, diversity, pay equity, transparency and reducing the impact our products have on the environment," said Tom Polen, CEO of BD in a statement. "We've made commitments that build on our purpose of advancing the world of health, and true to our culture, we're delivering on those commitments and positioning BD for sustainable growth and resilience."
Read These Related Articles:
Stay Up-To-Date
